Biological medicine in China is expected to form a situation analysis
2013/8/16 view:
Chinese medicine business association executive director FuMingZhong recently predicted at the 69th drug fairs, biological medicine industry is expected to form 600 billion to 800 billion yuan in the future market, its rapid growth by each segment need to bring.
First of all, the new vaccine market demand, improve the prevention and control of major infectious diseases prevention and control ability, can produce 100 billion yuan to 150 billion yuan scale vaccine market; Second, antibody and protein drugs such as biotech drugs market future can produce 300 billion yuan to 500 billion yuan; Major disease diagnosis and testing technology products will form a 50 billion yuan market; Personalized therapeutic drug is expected to form a 100 billion yuan market; Regeneration medical technology in the market, such as lack of organs, can be formed at least 50 billion yuan scale regeneration treatment and rehabilitation of the market.
China pharmaceutical industry information center, chief analyst at Zhu Jianying said that from 2012 medical market of the small molecule industry, biological products industry is the most profitable sector in the pharmaceutical industry. In 2012 sales income 177.543 billion yuan, the biological drugs manufacture industry rose 18.84%; Complete total profit of 23.013 billion yuan, increased by 14.3% year-on-year.
First of all, the new vaccine market demand, improve the prevention and control of major infectious diseases prevention and control ability, can produce 100 billion yuan to 150 billion yuan scale vaccine market; Second, antibody and protein drugs such as biotech drugs market future can produce 300 billion yuan to 500 billion yuan; Major disease diagnosis and testing technology products will form a 50 billion yuan market; Personalized therapeutic drug is expected to form a 100 billion yuan market; Regeneration medical technology in the market, such as lack of organs, can be formed at least 50 billion yuan scale regeneration treatment and rehabilitation of the market.
China pharmaceutical industry information center, chief analyst at Zhu Jianying said that from 2012 medical market of the small molecule industry, biological products industry is the most profitable sector in the pharmaceutical industry. In 2012 sales income 177.543 billion yuan, the biological drugs manufacture industry rose 18.84%; Complete total profit of 23.013 billion yuan, increased by 14.3% year-on-year.
- Pre：For an explanation of active p 2013/8/16
- Next：China international chemical i 2013/8/16